Evidence and topics of chemotherapy for hepatocellular carcinoma.

Kazuomi Ueshima; Masatoshi Kudo

doi:10.11405/nisshoshi.114.1621

Back

Shared by

Masatoshi Kudo

Evidence and topics of chemotherapy for hepatocellular carcinoma.

Article 2018 en

Authors

KU
Kazuomi Ueshima
Masatoshi Kudo

Related publications

Article2018

Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy

Ken Kamata, Mamoru Takenaka, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Toshiharu Sakurai, Tomohiro Watanabe, Masatoshi Kudo, Naoshi Nishida, Takafumi Nishimura, Toshimi Kaido, Kosuke Minaga, Kentaro Yamao

Discussion(0)

Sign in to like and join the discussion.

No comments yet. Be the first to comment.

Article2012

Medical therapies for hepatocellular carcinoma: a critical view of the evidence

Augusto Villanueva, Virginia Hernández‐Gea, Josep M. Llovet

Nature Reviews Gastroenterology & Hepatology

Article2002

Evidence‐based medicine in the treatment of hepatocellular carcinoma

Josep M. Llovet

Journal of Gastroenterology and Hepatology

Article2015

Evidence and Consensus on the Management of Hepatocellular Carcinoma: Update 2015

Masatoshi Kudo

Article2017

Resminostat and sorafenib combination therapy for advanced hepatocellular carcinoma in patients previously untreated with systemic chemotherapy.

Masatoshi Kudo, Baek‐Yeol Ryoo, Ho Yeong Lim, Do Young Kim, Takuji Okusaka, Masafumi Ikeda, Hisashi Hidaka, Jong-Eun Yeon, Eishiro Mizukoshi, Manabu Morimoto, Myung Ah Lee, Kohichiroh Yasui, Yasunori Kawaguchi, Jeong Heo, Sojiro Morita, Tae‐You Kim, Junji Furuse, Kazuhiro Katayama, Takeshi Aramaki, Won Young Tak